http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110064077-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-047 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04 |
filingDate | 2019-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110064077-B |
titleOfInvention | Silk fibroin hydrogel for uterine cavity adhesion treatment |
abstract | The invention provides silk fibroin hydrogel for uterine cavity adhesion treatment, which mainly comprises silk fibroin, poloxamer, cyclic dipeptide, liquid fluorocarbon and green indole phthalocyanine, wherein the green indole phthalocyanine has a photothermal effect, and the liquid fluorocarbon can be quickly converted into gas under the action of heat energy. Therefore, after the silk fibroin hydrogel for uterine cavity adhesion treatment is administered by applying an in-situ injection mode in the uterine cavity, the silk fibroin hydrogel can be rapidly expanded to form elastic three-dimensional hydrogel full of pores by irradiating in the uterine cavity by applying 785nm near infrared light, and the silk fibroin hydrogel is used for the efficient treatment of the uterine cavity adhesion. |
priorityDate | 2019-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.